checkAd

     130  0 Kommentare Integra LifeSciences Announces Definitive Agreement to Acquire ACell, Inc. - Seite 3

    These forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events, or otherwise.

    Discussion of Adjusted Financial Measures

    The Company believes that the presentation of organic revenues and the other non-GAAP measures, provide important supplemental information to management and investors regarding financial and business trends relating to the Company's financial condition and results of operations. For further information regarding why Integra believes that these non-GAAP financial measures provide useful information to investors, the specific manner in which management uses these measures, and some of the limitations associated with the use of these measures, please refer to the Company's Current Report on Form 8-K regarding this news release filed today with the Securities and Exchange Commission. This Current Report on Form 8-K is available on the SEC's website at www.sec.gov or on our website at www.integralife.com.

    Investor Relations Contact
    Michael Beaulieu
    Director, Investor Relations
    (609) 529-4812
    michael.beaulieu@integralife.com

    Media Contact:
    Laurene Isip
    Senior Director, Global Corporate Communications
    (609) 750-7984
    laurene.isip@integralife.com

     


    Seite 3 von 3



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Integra LifeSciences Announces Definitive Agreement to Acquire ACell, Inc. - Seite 3 Adds proprietary technology platform and complementary products to grow Integra’s regenerative portfolioPRINCETON, N.J., Dec. 16, 2020 (GLOBE NEWSWIRE) - Integra LifeSciences Holdings Corporation (NASDAQ:IART) a leading global medical technology …